Opportunity

SAM #36E79726R0029

Dutasteride 0.5MG Capsules Procurement for Federal Healthcare Agencies

Buyer

VA National Acquisition Center Pharmaceuticals

Posted

June 16, 2026

Respond By

July 07, 2026

Identifier

36E79726R0029

NAICS

325412, 424210

This opportunity involves the Department of Veterans Affairs National Acquisition Center seeking suppliers for Dutasteride 0.5MG Capsules to support multiple federal healthcare agencies. - Government Buyer: - Department of Veterans Affairs (VA), National Acquisition Center (NAC Pharmaceuticals, Hines, IL) - Also serving Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC) - Products Requested: - Dutasteride 0.5MG Capsules - 30-count bottles: estimated annual quantity of 3,912 bottles - 90-count bottles: estimated annual quantity of 25,502 bottles - Requirements: - Each offeror must provide a unique National Drug Code (NDC) number - Only the offeror's label may appear on the product - Packaging must include safety caps, minimum bottle volume, and specific label dimensions - Contract Details: - One-year base period with four pre-priced one-year option periods (up to five years total) - OEMs and Vendors: - No specific OEMs or vendors are named; open to all qualified manufacturers of Dutasteride 0.5MG Capsules

Description

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0029 for an unrestricted procurement for Dutasteride Capsules, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD) (inclusive of Tricare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere on top of the successful offeror/contractor s label. All unit of use packaging identified in the Schedule of Supplies, (Line items 1 and 2, 30 and 90 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation # 36E79726R0029 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about June 22, 2026, with a tentative closing date of July 7, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Richard Mahario. Questions can be e-mailed to Richard.Mahario@va.gov. The estimated annual requirements are as follows:

REQUIREMENT DESCRIPTION ITEM DESCRIPTION PACKAGE SIZE (Tablets per Bottle) TOTAL ESTIMATED ANNUAL USAGE (Bottles) 1 Dutasteride 0.5MG Capsules 30 3,912 2 Dutasteride 0.5MG Capsules 90 25,502

View original listing